Chromostatin bovine is a chromogranin A (CGA) derivative peptide, which inhibits postassium or carbamoylcholine induced catecholamine release with an ID50 of 5 nM. Chromostatin bovine reduces calcium flux, enhances the desensitization process of the cholinergic-evoked secretory response and modulates the endocrine response associated with catecholamine.

DS-2330 is a phosphorous lowering agent for treating hyperphosphatemia in chronic kidney disease.

Nonapeptide-1 can inhibit the synthesis of melanin which makes it of interest for treating certain skin conditions.?